After the passing of the 39th President of the United States, Jimmy Carter, we take a look back at 10 defining moments from ...
Goldman Sachs chief economist Jan Hatzius is bullish on the outlook for the U.S. economy, in large part because he doubts Donald Trump's incoming administration will be able to make good on its ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Two battery energy storage facilities achieved commercial operation in Texas, along with the transfer of investment tax ...
The U.S. auto industry is bracing for a shifting landscape, marked by the economic policies and global trade strategies of a ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...
Democrats in the House and Senate reintroduced Thursday legislation to permanently extend enhanced subsidies to help people ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...
The EV tax credit, designed to help America lead in one of the world’s fastest-growing markets, should be preserved.
Warner and Tim Kaine (both D-VA) recently celebrated a provision of the Inflation Reduction Act that will go into effect on January 1, 2025 to cap out-of-pocket costs for prescription drugs at $2,000 ...
The U.S. Department of Energy Bioenergy Technologies Office and the U.S. Environmental Protection Agency announced $6 MM in funding for three projects that will advance biofuel development and support ...